Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-27

Clinical Trial Update: Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 Years

View source ↗

Summary

A completed clinical trial evaluating the efficacy and tolerability of intranasal fentanyl spray for breakthrough pain in adult cancer patients; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • intranasal fentanyl spray (fentanyl)

Snippet

Sponsor: Takeda | Conditions: Breakthrough Pain, Cancer | Status: COMPLETED | Results posted: 2012-09-27